Nasus Pharma’s IPO: A Clinical-Stage Breakthrough Aiming to Raise $11 Million
Nasus Pharma Ltd., a clinical-stage pharmaceutical company headquartered in Tel Aviv, is preparing to launch its initial public offering (IPO) on the NYSE American...
McKinley Acquisition Targets Progressive Industries with $150 Million SPAC Launch
McKinley Acquisition Corporation (NASDAQ: MKLYU) has stepped into the public markets with a $150 million initial public offering, positioning itself as a next-generation special...
Highview Merger Corp. Launches $200 Million IPO: A Strategic Move in the SPAC Market
Highview Merger Corp., a newly formed special purpose acquisition company (SPAC) targeting middle-market businesses in North America and Western Europe, has successfully priced its...
U.S. IPO Market 2025: A Tentative Renaissance in Public Offerings
After a prolonged pause, the U.S. IPO market in 2025 is showing signs of a cautious yet meaningful resurgence. While the year began slowly,...
Miami International Holdings Targets $300 Million in IPO Amid Expanding Exchange Landscape
Miami International Holdings, Inc. (MIAX), a diversified exchange operator with a growing footprint in the U.S. and global financial markets, is preparing to go...
